Neutropenia Clinical Trials

A listing of Neutropenia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

California

La Jolla California 92093

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Long Beach California

A clinical research study of Tbo-filgrastim for the treatment of Solid Tumors

Los Angeles California

A clinical research study of Tbo-filgrastim for the treatment of Solid Tumors

Georgia

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Indiana

Indianapolis Indiana 46237

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Maryland

Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

Massachusetts

Worcester Massachusetts 01655

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Minnesota

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Mississippi

Jackson Mississippi

A clinical research study of Tbo-filgrastim for the treatment of Solid Tumors

Nevada

Las Vegas Nevada

A clinical research study of Tbo-filgrastim for the treatment of Solid Tumors

New York

New York New York 10065

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Pennsylvania

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Austria

Eggenburg 3730

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Graz 8036

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Leoben 8700

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Schwarzach im Pongau 5620

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Wien 1030

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

View More ▼

Wien 1090

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Belgium

Arlon 6700

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Liège 4000

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Bulgaria

Pleven 5800

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Plovdiv

Patients are needed to participate in a clinical research study of MYL-1401H and Neulasta to evaluate Breast Neoplasms or Chemotherapy-Induced Febrile Neutropenia

Plovdiv

Patients are needed to participate in a clinical research study of MYL-1401H and Neulasta to evaluate Breast Neoplasms or Chemotherapy-Induced Febrile Neutropenia

Plovdiv

Patients are needed to participate in a clinical research study of MYL-1401H and Neulasta to evaluate Breast Neoplasms or Chemotherapy-Induced Febrile Neutropenia

Sofia 1756

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

View More ▼

Sofia

Patients are needed to participate in a clinical research study of MYL-1401H and Neulasta to evaluate Breast Neoplasms or Chemotherapy-Induced Febrile Neutropenia

Sofia

Patients are needed to participate in a clinical research study of MYL-1401H and Neulasta to evaluate Breast Neoplasms or Chemotherapy-Induced Febrile Neutropenia

Tarnovo

Patients are needed to participate in a clinical research study of MYL-1401H and Neulasta to evaluate Breast Neoplasms or Chemotherapy-Induced Febrile Neutropenia

Varna

Patients are needed to participate in a clinical research study of MYL-1401H and Neulasta to evaluate Breast Neoplasms or Chemotherapy-Induced Febrile Neutropenia

China

Beijing

A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia

Beijing Beijing 100021

Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia

Beijing 100021

Patients are needed to participate in a clinical research study of HSA-GCSF 1.2 mg, HSA-GCSF 1.5 mg and Granulocyte Colony-Stimulating Factor (GCSF) to evaluate Chemotherapy-induced Neutropenia

Beijing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

View More ▼

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Guangzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai 200032

A clinical research study of F-627, Filgrastim and Epirubicin and Cyclophosphamide for the treatment of Neutropenia

Shanghai Shanghai 200433

A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia

Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Tianjin Tianjin 300060

Patients are needed to participate in a clinical research study evaluating GW003 for the treatment of Chemotherapy-induced Neutropenia or Metastatic Tumors

Wuhan

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Xiamen

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Zhejiang

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Czech Republic

Horovice 268 31

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Novy Jicin 741 01

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia